Engineering Blood Cells | The Enterprise Sessions with Profs Ash Toye and Jan Frayne

In this episode of Enterprise Sessions from the University of Bristol, Professor Michele Barbour sits down with Professor Ash Toye and Professor Jan Frayne, two leading biochemists whose long‑standing research partnership has evolved into one of the UK’s most exciting biotechnology spin‑outs: Scarlet Therapeutics. Together, Ash and Jan share the remarkable journey from academic collaboration to scientific breakthrough — and ultimately to founding a company built on the promise of lab‑grown an...